University of Khartoum

Absence of K13 gene mutations among artesunate/sulfadoxine– pyrimethamine treatment failures of Sudanese Plasmodium falciparum isolates from Damazin, southeast Sudan

Absence of K13 gene mutations among artesunate/sulfadoxine– pyrimethamine treatment failures of Sudanese Plasmodium falciparum isolates from Damazin, southeast Sudan

Show full item record

Title: Absence of K13 gene mutations among artesunate/sulfadoxine– pyrimethamine treatment failures of Sudanese Plasmodium falciparum isolates from Damazin, southeast Sudan
Author: Abdel Hamid, Muzamil Mahdi; Abdallah, Walla M. E.; Hussien, Maazza; Mohammed, Niven M.; Malik, Elfatih M.; Ahmed, Mohamed E.; Mohamed, Abdelrahim O.
Abstract: Background: The emergence of resistant parasites to artemisinin poses a threat to malaria treatment. The study aimed to investigate K13 gene mutations in Plasmodium falciparum artesunate (AS)/sulfadoxine–pyrimethamine (SP) efficacy study in Sudan. Methods: A total of 31 (14 failures and 17 adequate clinical and parasitological response [ACPR]) pretreatment dried blood samples from patients with uncomplicated P. falciparum malaria treated with AS/SP were examined. Nested polymerase chain reaction (PCR) and DNA sequencing of the K13 gene was performed. Results: PCR products were obtained from 30 (96.8%) samples and sequencing was successful in 28 (90.3%). No mutation of the K13 gene was recorded in the treatment failure group. A single mutation (C>T; A621V) in one ACPR patient sample was detected. Conclusion: There is no evidence of K13 mutation among AS/SP treatment failure patients. A single mutation of the K13 gene not linked to treatment failure has been detected.
URI: http://khartoumspace.uofk.edu/123456789/27090


Files in this item

Files Size Format View

This item appears in the following Collection(s)

Show full item record

Share

Search DSpace


Browse

My Account